We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
ATN International
ATNI
$370M
| $418K | ﹤0.01% |
10,224
+1,616
| +19% | +$71.4K |
|
|
CLDT
1677
Chatham Lodging
CLDT
$638M
| $417K | ﹤0.01% |
39,750
+10,850
| +38% | +$133K |
|
1678
Scansource
SCSC
$1.16B
| $406K | ﹤0.01% |
13,352
+1,450
| +12% | +$45K |
|
1679
Nuvation Bio
NUVB
$2.33B
| $397K | ﹤0.01% |
239,331
+3,206
| +1% | +$6.5K |
|
1680
TTEC Holdings
TTEC
$119M
| $397K | ﹤0.01% |
10,650
+700
| +7% | +$31.3K |
|
1681
Hawkins
HWKN
$2.99B
| $389K | ﹤0.01% |
8,882
+2,500
| +39% | +$101K |
|
|
GRTX
1682
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $389K | ﹤0.01% |
151,777
| – | – |
|
|
TBI
1683
Trueblue
TBI
$235M
| $388K | ﹤0.01% |
21,803
+2,550
| +13% | +$47.7K |
|
|
HSII
1684
DELISTED
Heidrick & Struggles
HSII
| $387K | ﹤0.01% |
12,750
+2,400
| +23% | +$73.5K |
|
1685
Harmony Biosciences
HRMY
$2.07B
| $382K | ﹤0.01% |
11,710
+300
| +3% | +$13.7K |
|
1686
Legend Biotech
LEGN
$3.68B
| $379K | ﹤0.01% |
7,850
+2,700
| +52% | +$132K |
|
|
TBRG
1687
DELISTED
TruBridge
TBRG
| $378K | ﹤0.01% |
12,530
+2,450
| +24% | +$71.4K |
|
1688
Hess Midstream
HESM
$5.13B
| $374K | ﹤0.01% |
12,920
| – | – |
|
|
FLNA
1689
Filana Therapeutics
FLNA
$42.7M
| $369K | ﹤0.01% |
15,280
+2,450
| +19% | +$67.9K |
|
1690
DMC Global
BOOM
$112M
| $357K | ﹤0.01% |
16,250
| – | – |
|
1691
Kanzhun
BZ
$7.07B
| $357K | ﹤0.01% |
18,750
+5,200
| +38% | +$113K |
|
1692
Customers Bancorp
CUBI
$2.69B
| $355K | ﹤0.01% |
19,154
+150
| +0.8% | +$4.09K |
|
1693
Interface
TILE
$2B
| $355K | ﹤0.01% |
43,674
+19,000
| +77% | +$187K |
|
|
BGFV
1694
DELISTED
Big 5 Sporting Goods
BGFV
| $354K | ﹤0.01% |
46,002
| – | – |
|
1695
Lindblad Expeditions
LIND
$1.95B
| $353K | ﹤0.01% |
36,920
| – | – |
|
1696
PetMed Express
PETS
$43M
| $353K | ﹤0.01% |
21,727
+550
| +3% | +$10.4K |
|
1697
TSMC
TSM
$2.03T
| $349K | ﹤0.01% |
3,757
-154,043
| -98% | -$13.8M |
|
1698
Lightwave Logic
LWLG
$887M
| $348K | ﹤0.01% |
66,600
+7,600
| +13% | +$42.4K |
|
|
PRSU
1699
Pursuit Attractions and Hospitality Inc
PRSU
$1.48B
| $346K | ﹤0.01% |
16,580
+900
| +6% | +$22.4K |
|
1700
Artivion
AORT
$1.31B
| $343K | ﹤0.01% |
26,200
+6,850
| +35% | +$87.5K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.